June 20, 2026 · Form 4 insider transaction
KLEMP WALTER V bought 150 shares of Moleculin Biotech, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Restricted stock units convert into common stock on a one-for-one basis.